Michal Homolac
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michal Homolac has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Anna Svejdova
Department of Otorhinolaryngology and Head and Neck Surgery University Hospital Hradec Kralove Hradec Kralove Czech Republic
3 shared publications - Viktor Chrobok
Department of Otorhinolaryngology and Head and Neck Surgery University Hospital Hradec Kralove Hradec Kralove Czech Republic
3 shared publications Jana Dedkova
Department of Diagnostic Radiology University Hospital Hradec Kralove Hradec Kralove Czech Republic
2 shared publications- Lukas Skoloudik
Department of Otorhinolaryngology and Head and Neck Surgery University Hospital Hradec Kralove Hradec Kralove Czech Republic
2 shared publications - Jakub Drsata
Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czechia
1 shared publication - Jan Laco
The Fingerland Department of Pathology, University Hospital Hradec Kralové, Hradec Králové, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 5 November 2026
- Published by Wiley in The Laryngoscope
Cholesteatoma Recidivism in Pediatric Versus Adult Patients: Disease Extent and Prognostic Factors
Objective: To determine whether pediatric age independently predicts cholesteatoma recidivism beyond anatomical disease extent using the EAONO/JOS and SAMEO‐ATO classifications. Methods: A retrospective cohort study of 128 primary cholesteatoma surgeries (128 ears in 126 patients; median follow‐up, 5.8 years) was conducted. Etiology, stage, topographical extension (STAM), and surgical category (SAMEO‐ATO) were recorded. A data‐driven threshold (< 20 years) was identified via maximally selected rank statistics. Predictors were determined by Group Lasso selection and Firth's penalized Cox regression. Results: Recidivism was identified in 21 of 43 pediatric and 16 of 85 adult ears. The 5‐year cumulative risk was 53.9% (95% CI, 34.2%–67.8%) in children versus 19.1% (95% CI, 9.5%–27.7%) in adults (log‐rank p < 0.001), driven by early residual disease ( p = 0.004) rather than true recurrence ( p = 0.058). The sinus tympani (S2) was a site of recidivism in 38.5% of pediatric versus 5.6% of adult cases ( p = 0.016). Multivariable analysis identified four independent predictors: pediatric age (hazard ratio [HR] 2.24; 95% CI, 1.09–4.63), supratubal recess involvement (HR 3.41; 95% CI, 1.56–7.45), mastoid extension (HR 2.43; 95% CI, 1.01–5.84), and absence of mastoidectomy relative to canal wall‐down technique (HR 8.67; 95% CI, 1.95–38.41). Conclusion: Pediatric age, supratubal recess involvement, mastoid extension, and mastoidectomy omission relative to canal wall‐down technique independently predict cholesteatoma recidivism. The predominance of residual over recurrent disease, with a median detection interval of approximately 14 months, supports active 12–18 month postoperative surveillance and long‐term clinical follow‐up on a risk‐stratified basis. Level of Evidence: 3.
- 5 November 2026
- Published by Wiley in The Laryngoscope
Open AccessCholesteatoma Recidivism in Pediatric Versus Adult Patients: Disease Extent and Prognostic Factors
Objective: To determine whether pediatric age independently predicts cholesteatoma recidivism beyond anatomical disease extent using the EAONO/JOS and SAMEO‐ATO classifications. Methods: A retrospective cohort study of 128 primary cholesteatoma surgeries (128 ears in 126 patients; median follow‐up, 5.8 years) was conducted. Etiology, stage, topographical extension (STAM), and surgical category (SAMEO‐ATO) were recorded. A data‐driven threshold (< 20 years) was identified via maximally selected rank statistics. Predictors were determined by Group Lasso selection and Firth's penalized Cox regression. Results: Recidivism was identified in 21 of 43 pediatric and 16 of 85 adult ears. The 5‐year cumulative risk was 53.9% (95% CI, 34.2%–67.8%) in children versus 19.1% (95% CI, 9.5%–27.7%) in adults (log‐rank p < 0.001), driven by early residual disease ( p = 0.004) rather than true recurrence ( p = 0.058). The sinus tympani (S2) was a site of recidivism in 38.5% of pediatric versus 5.6% of adult cases ( p = 0.016). Multivariable analysis identified four independent predictors: pediatric age (hazard ratio [HR] 2.24; 95% CI, 1.09–4.63), supratubal recess involvement (HR 3.41; 95% CI, 1.56–7.45), mastoid extension (HR 2.43; 95% CI, 1.01–5.84), and absence of mastoidectomy relative to canal wall‐down technique (HR 8.67; 95% CI, 1.95–38.41). Conclusion: Pediatric age, supratubal recess involvement, mastoid extension, and mastoidectomy omission relative to canal wall‐down technique independently predict cholesteatoma recidivism. The predominance of residual over recurrent disease, with a median detection interval of approximately 14 months, supports active 12–18 month postoperative surveillance and long‐term clinical follow‐up on a risk‐stratified basis. Level of Evidence: 3.
- Open Access
- 25 June 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (12) , 5131-5134
Bilateral Otic Manifestation of Pseudogout: A Unique Case Report of Conductive Hearing Loss
Pseudogout is characterized by the deposition of calcium pyrophosphate dihydrate crystals (CPPD), primarily affecting large joints. Extra‐articular manifestations, particularly in the head and neck region, are exceedingly rare. We report a unique case of bilateral isolated pseudogout of the middle ear manifesting with progressive conductive hearing loss as the first and only symptom of pseudogout. Otoscopy and CT scan often yield a differential diagnosis that includes tumors or cholesteatoma, necessitating surgery with histopathological examination. The definitive diagnosis is confirmed upon identification of calcium pyrophosphate dihydrate crystals. In most cases, removal of the crystals results in resolution of conductive hearing loss. Laryngoscope, 134:5131–5134, 2024
- 25 June 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (12) , 5131-5134
Open AccessBilateral Otic Manifestation of Pseudogout: A Unique Case Report of Conductive Hearing Loss
Pseudogout is characterized by the deposition of calcium pyrophosphate dihydrate crystals (CPPD), primarily affecting large joints. Extra‐articular manifestations, particularly in the head and neck region, are exceedingly rare. We report a unique case of bilateral isolated pseudogout of the middle ear manifesting with progressive conductive hearing loss as the first and only symptom of pseudogout. Otoscopy and CT scan often yield a differential diagnosis that includes tumors or cholesteatoma, necessitating surgery with histopathological examination. The definitive diagnosis is confirmed upon identification of calcium pyrophosphate dihydrate crystals. In most cases, removal of the crystals results in resolution of conductive hearing loss. Laryngoscope, 134:5131–5134, 2024
- 20 December 2021
- Published by Care Comm in Otorinolaryngologie a foniatrie
- Vol. 70 (4) , 214-222
The value of flexible endoscopy with Narrow Band Imaging for the evaluation of recurrence of laryngeal and hypopharyngeal tumours after radiotherapy
Background: The diagnosis of recurrent upper aerodigestive tumours is difficult, especially in the case of previous curative radiotherapy (RT) or chemoradiotherapy (CRT). Progress in the diagnostics of head and neck cancer came with the development of optical endoscopic imaging methods. The aim of this study was to analyse the benefits of flexible Narrow Band Imaging (NBI) in the visualization of suspected recurrence of malignancy in patients after curative RT (CRT). Methods: A total of 58 examined patients in follow-up after curative RT or CRT for laryngeal and hypopharyngeal squamous cell carcinoma were enrolled in the study. All patients underwent transnasal flexible endoscopy in conventional white light and NBI in local anaesthesia. Changes in microvascular architecture (intraepithelial papillary capillary loops – IPCL) have been classified according to Ni. IPCL I–III were considered to be non-suspicious, and therefore no histopathological examination was indicated. IV and V type findings were verified using HDTV NBI intraoperatively with biopsy sampling and subsequent histopathological correlation was performed. Results: Transnasal videoendoscopic examination with NBI revealed a suspicious finding (IPCL type IV and V) in 23/58 (39.7%) patients, non-suspicious finding (IPCL I–III) in 35/58 (60.3%). Histopathological examination verified the positive finding (precancerous or malignant changes) in 12/23 (52.2%) and negative finding in 11/23 (47.8%) cases. The sensitivity, specificity, positive and negative predictive value of flexible NBI endoscopy were 100%, 76.1%, 52.2% and 100% respectively. According to the Kappa index (K = 0.568), we proved a moderate concordance between flexible NBI endoscopy and histopathological results. Conclusions: Transnasal flexible endoscopy with NBI in outpatient settings contributes to an early detection of pathological changes also in post-radiation altered mucosa of the larynx and hypopharynx, while a correct interpretation of in NBI findings is required to reduce the incidence of false positive results. Keywords: squamous cell carcinoma – Larynx – radiotherapy – narrow band imaging – Ni classification – hypopharynx
- 20 December 2021
- Published by Care Comm in Otorinolaryngologie a foniatrie
- Vol. 70 (4) , 214-222
The value of flexible endoscopy with Narrow Band Imaging for the evaluation of recurrence of laryngeal and hypopharyngeal tumours after radiotherapy
Background: The diagnosis of recurrent upper aerodigestive tumours is difficult, especially in the case of previous curative radiotherapy (RT) or chemoradiotherapy (CRT). Progress in the diagnostics of head and neck cancer came with the development of optical endoscopic imaging methods. The aim of this study was to analyse the benefits of flexible Narrow Band Imaging (NBI) in the visualization of suspected recurrence of malignancy in patients after curative RT (CRT). Methods: A total of 58 examined patients in follow-up after curative RT or CRT for laryngeal and hypopharyngeal squamous cell carcinoma were enrolled in the study. All patients underwent transnasal flexible endoscopy in conventional white light and NBI in local anaesthesia. Changes in microvascular architecture (intraepithelial papillary capillary loops – IPCL) have been classified according to Ni. IPCL I–III were considered to be non-suspicious, and therefore no histopathological examination was indicated. IV and V type findings were verified using HDTV NBI intraoperatively with biopsy sampling and subsequent histopathological correlation was performed. Results: Transnasal videoendoscopic examination with NBI revealed a suspicious finding (IPCL type IV and V) in 23/58 (39.7%) patients, non-suspicious finding (IPCL I–III) in 35/58 (60.3%). Histopathological examination verified the positive finding (precancerous or malignant changes) in 12/23 (52.2%) and negative finding in 11/23 (47.8%) cases. The sensitivity, specificity, positive and negative predictive value of flexible NBI endoscopy were 100%, 76.1%, 52.2% and 100% respectively. According to the Kappa index (K = 0.568), we proved a moderate concordance between flexible NBI endoscopy and histopathological results. Conclusions: Transnasal flexible endoscopy with NBI in outpatient settings contributes to an early detection of pathological changes also in post-radiation altered mucosa of the larynx and hypopharynx, while a correct interpretation of in NBI findings is required to reduce the incidence of false positive results. Keywords: squamous cell carcinoma – Larynx – radiotherapy – narrow band imaging – Ni classification – hypopharynx